Summary
Plasma levels of nortriptyline and perphenazine were measured in six patients on continuous nortriptyline treatment before, during and after oral administration of perphenazine 4 mg t.i.d. In four patients the plasma levels of the conjugated and unconjugated principal metabolite 10-hydroxy-nortriptyline were also measured. Urinary excretion of conjugated and unconjugated 10-hydroxy-nortriptyline and plasma levels of perphenazine were determined in all six patients. During treatment with perphenazine two patients showed a slight increase in the plasma level of nortriptyline. The changes in metabolite excretion rate were inconclusive. Thus, there did not appear to be any important pharmacokinetic interaction between the two drugs at the doses used, which were normal therapeutic doses. The previously reported inhibitory effect of perphenazine on the metabolism of nortriptyline probably depended therefore, either on administration of a higher dose of perphenazine, or on treatment in the reverse sequence — a single dose of nortriptyline was given to patients already receiving perphenazine.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alexanderson, B., Borgå, O.: Urinary excretion of nortriptyline and five of its metabolites in man after single and multiple oral doses. Europ. J. clin. Pharmacol.5, 174–180 (1973)
von Bahr, C.: Binding and oxidation of amitriptyline and a series of its oxidized metabolites in liver microsomes from untreated and phenobarbital treated rats. Xenobiotica2, 293–306 (1972)
Borgå, O., Palmér, L., Sjöqvist, F., Holmstedt, B.: Mass fragmentography used in quantitative analysis of drugs and endogenous compounds in biological fluids. In: Symposium on the Basis of Drug Therapy in Man. Fifth Internat. Pharmacol. Congr., San Francisco, July 1972. Vol 3. C/9. pp 56–68 (1973)
Hammer, W., Sjöqvist, F.: Inhibition of the metabolism of tremorine and oxotremorine in rats by antidepressants of the imipramine-type. In: Proc. First Internat. Symposium on Antidepressant Drugs. Milan, 1966, Ed. S. Garattini and M.N.G. Dukes: Excerpta Med.Internat. Congr. Ser. No. 122, 279–289. Amsterdam: Excerpta Medica 1967
Hansen, C.E., Larsen, N.E.: Perphenazine concentrations in human whole blood. Psychopharmacologia37, 31–36 (1974)
Hansen, C.E., Christensen, T.R., Elley, J., Hansen, L.B., Kragh-Sørensen, P., Larsen, N.-E., Næstoft, J., Hvidberg, E.F.: Clinical pharmacokinetic studies of perphenazine. Brit. J. clin. Pharmacol.3, 915–923 (1976)
Gram, L.F., Fredricson-Overø, K.: Drug interaction: Inhibitory effects of the neuroleptics on metabolism of tricyclic antidepressants in man. Brit. Med. J.1972 I, 463–465
Gram, L.F., Fredricson-Overø, K., Kirk, L.: Influence of neuroleptics and benzodiazepines on metabolism of tricyclic antidepressants in man. Amer. J. Psychiatry131:8, 863–866 (1974a)
Gram, L.F., Christiansen, J., Fredricson-Overø, K.: Pharmacokinetic interaction between neuroleptics and tricyclic antidepressants in the rat. Acta Pharmacol. Toxicol.35, 223–232 (1974b)
Gram, L.F.: Effects of perphenazine on imipramine metabolism in man. Psychopharmacol. Comm.1, 165–175 (1975)
Kragh-Sørensen, P., Hansen, C.E., Asberg, M.: Plasmanortriptyline levels in endogenous depression. Lancet1973 I, 113–115
Kragh-Sørensen, P., Hansen, C.E., Baastrup, P.C., Hvidberg, E.: Self-inhibiting action of nortriptylines antidepressive effect at high plasma levels. Psychopharmacology45, 305–312 (1976)
Larsen, N.E., Næstoft, J.: Determination of perphenazine and fluphenazine in whole blood by gas chromatography. Med. Lab. Technol.30, 129–132 (1973)
Moody, A., Tait, C., Todrick, A.: Plasma levels of imipramine and desmethylimipramine during therapy. Brit. J. Psychiatry113, 183–193 (1967)
Olivier-Martin, R., Marzin, D., Buschsen-Schutz, E., Pichot, P., Boissier, J.: Concentrations plasmatiques de l'imipramine et de la desmethyl-imipramine et effect anti-depresseur au cours d'en traitement controlé. Psychopharmacologia41, 187–195 (1975)
Sjöqvist, F., Hammer, W., Schumacher, H., Gillette, J.R.: The effect of desmethylimipramine and other “anti-tremorine” drugs on the metabolism of tremorine and oxotremorine in rats and mice. Biochem. Pharmacol.17, 915–934 (1968)
Sjöqvist, F.: Assessment of antidepressants — Pharmacokinetic aspects. In: Advanced Medicine Symposia: Topics in Therapeutics, (Ed. A. Breckenridge) pp 198–217. London: Pitman Medical 1975
Stevenson, I.H., Schiff, A.A.: The effect of fluphenazineon steady-state plasma levels of nortriptyline. Brit. J. Clin. Pharmacol.1, 337–338 (1974)
Åsberg, M., Cronholm, B., Sjöqvist, F., Tuck, D.: Relationship between plasma levels and therapeutic effect of nortriptyline. Brit. Med. J.1971 III, 331–334
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kragh-Sørensen, P., Borgå, O., Garle, M. et al. Effect of simultaneous treatment with low doses of perphenazine on plasma and urine concentrations of nortriptyline and 10-hydroxynortriptyline. Eur J Clin Pharmacol 11, 479–483 (1977). https://doi.org/10.1007/BF00562943
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00562943